October 24, 2012 9:58 PM

Patients who received drugs from suspect company being notified

Fifteen area hospitals and clinics in Kansas purchased drugs from the company linked to a deadly meningitis outbreak. The drugs have not been linked to any adverse effects or contamination, but are part of a precautionary recall by the U.S. Food and Drug Administration.

Related content